InsiderOther
David Altshuler Insider Trading Activity
Every SEC Form 4 transaction reported by David Altshuler, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is David Altshuler buying or selling?
David Altshuler reported 0 open-market buys ($0) and 67 sells ($70.3M) across 67 Form 4 filings at 1 company — a net selling position of $70.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of May 19, 2025)
Total Form 4 filings
67
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (67)
$70.3M
Insider sentiment
Net sellingNet insider flow of $70.3M in net selling, filed between May 16, 2018 – May 19, 2025.
Companies David Altshuler files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | VRTXVERTEX PHARMACEUTICALS INC / MA | 67 |
Recent David Altshuler transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| May 19, 2025 | VRTX | EVP, Chief Scientific Officer | Sale | 52 | $22.1K |
| Mar 17, 2025 | VRTX | EVP, Chief Scientific Officer | Sale | 3.2K | $1.6M |
| Mar 12, 2025 | VRTX | EVP, Chief Scientific Officer | Sale | 3.2K | $1.6M |
| Mar 5, 2025 | VRTX | EVP, Chief Scientific Officer | Sale | 3.2K | $1.6M |
| Feb 28, 2025 | VRTX | EVP, Chief Scientific Officer | Sale | 1.3K | $610.6K |
| Feb 26, 2025 | VRTX | EVP, Chief Scientific Officer | Sale | 848 | $407.8K |
| Feb 24, 2025 | VRTX | EVP, Chief Scientific Officer | Sale | 1.1K | $533.3K |
| Nov 19, 2024 | VRTX | EVP, Chief Scientific Officer | Sale | 15 | $7.2K |
| May 17, 2024 | VRTX | EVP, Chief Scientific Officer | Sale | 54 | $23.3K |
| Feb 27, 2024 | VRTX | EVP, Global Research and CSO | Sale | 4.2K | $1.8M |
| Feb 23, 2024 | VRTX | EVP, Global Research and CSO | Sale | 3.0K | $1.3M |
| Feb 21, 2024 | VRTX | EVP, Global Research and CSO | Sale | 4.0K | $1.7M |
| Feb 13, 2024 | VRTX | EVP, Global Research and CSO | Sale | 3.1K | $1.3M |
| Nov 17, 2023 | VRTX | EVP, Global Research and CSO | Sale | 19 | $7.0K |
| Aug 11, 2023 | VRTX | EVP, Global Research and CSO | Sale | 63 | $21.8K |
| Feb 28, 2023 | VRTX | EVP, Global Research and CSO | Sale | 4.2K | $1.2M |
| Feb 22, 2023 | VRTX | EVP, Global Research and CSO | Sale | 4.0K | $1.2M |
| Feb 16, 2023 | VRTX | EVP, Global Research and CSO | Sale | 6.4K | $1.9M |
| Feb 14, 2023 | VRTX | EVP, Global Research and CSO | Sale | 4.8K | $1.4M |
| Feb 8, 2023 | VRTX | EVP, Global Research and CSO | Sale | 1.3K | $399.0K |
| Nov 17, 2022 | VRTX | EVP, Global Research and CSO | Sale | 34 | $10.5K |
| Nov 9, 2022 | VRTX | EVP, Global Research and CSO | Sale | 1.3K | $394.9K |
| Aug 10, 2022 | VRTX | EVP, Global Research and CSO | Sale | 1.3K | $381.5K |
| Jul 21, 2022 | VRTX | EVP, Global Research and CSO | Sale | 17.9K | $5.2M |
| Feb 28, 2022 | VRTX | EVP, Global Research and CSO | Sale | 7.6K | $1.7M |
Showing the 25 most recent filings of 67. Screen every filing.
David Altshuler insider trading FAQ
Is David Altshuler buying or selling?
Across 67 SEC Form 4 filings, David Altshuler reported 0 open-market purchases totaling $0 and 67 sales totaling $70.3M — a net selling position of $70.3M.
Which companies does David Altshuler file Form 4s for?
David Altshuler has reported insider transactions at 1 company, most often VERTEX PHARMACEUTICALS INC / MA (VRTX).
How far back does David Altshuler's filing history go?
Trabud holds David Altshuler's SEC Form 4 filings from May 16, 2018 – May 19, 2025, sourced directly from SEC EDGAR.
Where does Trabud get David Altshuler's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track David Altshuler and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener